Showing results (1-10 of 24) with videos related to
Sort By:
Pageof 3
Drugs in R&D|November 1, 2006
A chaperone-mediated approach to enzyme enhancement as a therapeutic option for the lysosomal storage disordersGregory M Pastores, Swati SatheHeadache|February 28, 2009
Acute confusional migraine may be a presenting feature of CADASILSwati Sathe, Edgar DePeralta, Gregory Pastores, et al.Clinical Nuclear Medicine|July 14, 2020
The Use of FDG PET Parametric Imaging in the Diagnosis of Olivopontocerebellar AtrophyNassier Harfouch, Mark Finkelstein, Swati Sathe, et al.Movement Disorders : Official Journal of the Movement Disorder Society|June 1, 2026
Systematic Review of the Huntington's Disease Drug Development Pipeline, 2014 to 2025Pavlina Konstantinova, Jenny Townhill, Juliana Bronzova, et al.Neurogenetics|August 16, 2022
Expanding the phenotypic spectrum of Dejerine-Sottas syndrome caused by the trembler mutationMustafa Jaffry, Soumya Bouchachi, Mohsen Ahmed, et al.Movement Disorders : Official Journal of the Movement Disorder Society|December 6, 2021
A Machine-Learning Derived Huntington's Disease Progression Model: Insights for Clinical Trial DesignAmrita Mohan, Zhaonan Sun, Soumya Ghosh, et al.Oncogene|December 14, 2004
The AKT/I kappa B kinase pathway promotes angiogenic/metastatic gene expression in colorectal cancer by activating nuclear factor-kappa B and beta-cateninAnju Agarwal, Kingshuk Das, Natalia Lerner, et al.Frontiers in Aging Neuroscience|February 28, 2024
Large-scale screening of clinical assessments to distinguish between states in the Integrated HD Progression Model (IHDPM)Zhaonan Sun, Jennifer Ware, Sanjoy Dey, et al.Pediatric Neurology|March 25, 2008
Juvenile-onset G(M2)-gangliosidosis in an African-American child with nystagmusAlex R Paciorkowski, Swati Sathe, Bei-Jin Zeng, et al.Pageof 3